罕见病食疗专用医疗食品:现状与展望

IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL
Ting Zhang, Yun Wang, Cuiping Shi, Ye Zi, Wei Cai, Jian Zhong
{"title":"罕见病食疗专用医疗食品:现状与展望","authors":"Ting Zhang, Yun Wang, Cuiping Shi, Ye Zi, Wei Cai, Jian Zhong","doi":"10.5582/irdr.2025.01075","DOIUrl":null,"url":null,"abstract":"<p><p>Foods for special medical purposes (FSMPs) is a type of products that provides targeted nutritional support for specific diseases or physiological conditions. Compared with conventional dietary therapy, FSMPs are more targeted, safer, and applicable in clinic. When FSMPs are used to treat rare diseases, their core principle is to bypass or alleviate metabolic disorders. With the increasing recognition of clinical treatment effectiveness and the growing demand from patients, the types and market scale of commercial rare disease FSMPs continue to expand. However, there are currently no article summarized and analyzed the characteristics of diverse commercial products. Based on this, this review collected and collated the vast majority of commercial rare disease FSMPs in the global market, and summarized the characteristics of these products by categorizing them into protein substitutes, nutritional modules, ketogenic diets (KDs), and special low protein foods (SLPFs). Following the comprehensive analysis of the global commercial rare disease FSMPs landscape, this review shifted focus to China and provided suggestions from product diversity, technological innovation, and policy optimization. It aims to offer available suggestions and references for the healthy development of rare disease FSMPs in China.</p>","PeriodicalId":14420,"journal":{"name":"Intractable & rare diseases research","volume":"15 1","pages":"26-44"},"PeriodicalIF":1.6000,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12932013/pdf/","citationCount":"0","resultStr":"{\"title\":\"Foods for special medical purposes for the dietary therapy of rare diseases: Current status and future prospects.\",\"authors\":\"Ting Zhang, Yun Wang, Cuiping Shi, Ye Zi, Wei Cai, Jian Zhong\",\"doi\":\"10.5582/irdr.2025.01075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Foods for special medical purposes (FSMPs) is a type of products that provides targeted nutritional support for specific diseases or physiological conditions. Compared with conventional dietary therapy, FSMPs are more targeted, safer, and applicable in clinic. When FSMPs are used to treat rare diseases, their core principle is to bypass or alleviate metabolic disorders. With the increasing recognition of clinical treatment effectiveness and the growing demand from patients, the types and market scale of commercial rare disease FSMPs continue to expand. However, there are currently no article summarized and analyzed the characteristics of diverse commercial products. Based on this, this review collected and collated the vast majority of commercial rare disease FSMPs in the global market, and summarized the characteristics of these products by categorizing them into protein substitutes, nutritional modules, ketogenic diets (KDs), and special low protein foods (SLPFs). Following the comprehensive analysis of the global commercial rare disease FSMPs landscape, this review shifted focus to China and provided suggestions from product diversity, technological innovation, and policy optimization. It aims to offer available suggestions and references for the healthy development of rare disease FSMPs in China.</p>\",\"PeriodicalId\":14420,\"journal\":{\"name\":\"Intractable & rare diseases research\",\"volume\":\"15 1\",\"pages\":\"26-44\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2026-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12932013/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Intractable & rare diseases research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5582/irdr.2025.01075\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intractable & rare diseases research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/irdr.2025.01075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

特殊医疗用途食品(FSMPs)是针对特定疾病或生理状况提供有针对性的营养支持的一类产品。与传统饮食疗法相比,FSMPs更具针对性、安全性和临床适用性。当FSMPs用于治疗罕见疾病时,其核心原则是绕过或减轻代谢紊乱。随着人们对临床治疗效果认识的提高和患者需求的增长,罕见病商业化fsmp的种类和市场规模不断扩大。然而,目前还没有文章对各种商业产品的特点进行总结和分析。基于此,本文收集整理了全球市场上绝大多数的罕见病fsmp产品,并将其分为蛋白质替代品、营养模块、生酮饮食(KDs)和特殊低蛋白食品(SLPFs),总结了这些产品的特点。在全面分析全球罕见病商业化FSMPs格局的基础上,本文将重点转向中国,从产品多样性、技术创新和政策优化等方面提出建议。旨在为中国罕见病fsmp的健康发展提供建议和参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Foods for special medical purposes for the dietary therapy of rare diseases: Current status and future prospects.

Foods for special medical purposes (FSMPs) is a type of products that provides targeted nutritional support for specific diseases or physiological conditions. Compared with conventional dietary therapy, FSMPs are more targeted, safer, and applicable in clinic. When FSMPs are used to treat rare diseases, their core principle is to bypass or alleviate metabolic disorders. With the increasing recognition of clinical treatment effectiveness and the growing demand from patients, the types and market scale of commercial rare disease FSMPs continue to expand. However, there are currently no article summarized and analyzed the characteristics of diverse commercial products. Based on this, this review collected and collated the vast majority of commercial rare disease FSMPs in the global market, and summarized the characteristics of these products by categorizing them into protein substitutes, nutritional modules, ketogenic diets (KDs), and special low protein foods (SLPFs). Following the comprehensive analysis of the global commercial rare disease FSMPs landscape, this review shifted focus to China and provided suggestions from product diversity, technological innovation, and policy optimization. It aims to offer available suggestions and references for the healthy development of rare disease FSMPs in China.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Intractable & rare diseases research
Intractable & rare diseases research MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
29
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书